[AFSSAPS guideline for the treatment of dyslipidemia].

[AFSSAPS guideline for the treatment of dyslipidemia].

Item
http://www.wikidata.org/entity/Q46857843
How to translate therapeutic recommendations in clinical practice guidelines into rules for critiquing physician prescriptions? Methods and application to five guidelinesMeasuring preventive procedures by French GPs: an observational survey[Evaluation of the level of knowledge of patients on treatment with vitamin K antagonists in Ouagadougou cardiology department]Ineffectiveness of lipid-lowering therapy in primary care.Mixed dyslipidemias in primary care patients in France.Dyslipidemia in Patients with a Cardiovascular Risk and Disease at the University Teaching Hospital of Yaoundé, Cameroon.Lipid-lowering drugs associated with slower motor decline in the elderly adults.A generic system for critiquing physicians' prescriptions: usability, satisfaction and lessons learnt.Control of cardiovascular risk in black Africans with type 2 diabetes in Senegal.
P2860

[AFSSAPS guideline for the treatment of dyslipidemia].

Item
http://www.wikidata.org/entity/Q46857843
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
[AFSSAPS guideline for the treatment of dyslipidemia].
@en
[AFSSAPS guideline for the treatment of dyslipidemia].
@nl
type
label
[AFSSAPS guideline for the treatment of dyslipidemia].
@en
[AFSSAPS guideline for the treatment of dyslipidemia].
@nl
prefLabel
[AFSSAPS guideline for the treatment of dyslipidemia].
@en
[AFSSAPS guideline for the treatment of dyslipidemia].
@nl
P1433
P1476
P2093
P304
P31
P407
P433
P478
P577
P698
P921
P1433
P1476
[AFSSAPS guideline for the treatment of dyslipidemia]
@en
P2093
Agence Francaise de Securite Sanitaire des Produits de Sante
P304
P31
P407
P433
P478
P577
P698
P921